Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00176_DB06769_nanopub.RA_aADINAfGcp4WAgjaXzN514BEyE-nXe3hWfbnayaFhY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00176_DB06769 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00176_DB06769 label "DDI between Fluvoxamine and Bendamustine - Affects hepatic CYP1A2 metabolism, thus increasing bendamustine levels. Concentration of active metabolites may be decreased due to decreased conversion. [drugbank_resource:DB00176_DB06769]" assertion.
- drugbank_resource:DB00176_DB06769 identifier "drugbank_resource:DB00176_DB06769" assertion.
- drugbank_resource:DB00176_DB06769 title "DDI between Fluvoxamine and Bendamustine - Affects hepatic CYP1A2 metabolism, thus increasing bendamustine levels. Concentration of active metabolites may be decreased due to decreased conversion." assertion.
- drugbank:DB06769 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00176_DB06769 assertion.
- drugbank:DB00176 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00176_DB06769 assertion.